| Interleukin-6 receptor antagonists in critically ill patients with Covid-19–preliminary report Remap-Cap Investigators, AC Gordon, PR Mouncey, F Al-Beidh, ... Medrxiv, 2021.01. 07.21249390, 2021 | 1315 | 2021 |
| Therapeutic anticoagulation with heparin in noncritically ill patients with Covid-19 ATTACC, ACTIV-4a, and REMAP-CAP Investigators New England Journal of Medicine 385 (9), 790-802, 2021 | 1026 | 2021 |
| Effect of hydrocortisone on mortality and organ support in patients with severe COVID-19: the REMAP-CAP COVID-19 corticosteroid domain randomized clinical trial DC Angus, L Derde, F Al-Beidh, D Annane, Y Arabi, A Beane, ... Jama 324 (13), 1317-1329, 2020 | 817 | 2020 |
| Interleukin-6 receptor antagonists in critically ill patients with Covid-19 Remap-Cap Investigators New England Journal of Medicine 384 (16), 1491-1502, 2021 | 603 | 2021 |
| Effect of convalescent plasma on organ support–free days in critically ill patients with COVID-19: a randomized clinical trial H Abdelhady, M Abdelrazik, Z Abdi, D Abdo, A Abdulle, L Abel, ... Jama 326 (17), 1690-1702, 2021 | 190 | 2021 |
| Trends in US pediatric hospital admissions in 2020 compared with the decade before the COVID-19 pandemic JH Pelletier, J Rakkar, AK Au, D Fuhrman, RSB Clark, CM Horvat JAMA Network Open 4 (2), e2037227-e2037227, 2021 | 150 | 2021 |
| Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial YM Arabi, AC Gordon, LPG Derde, AD Nichol, S Murthy, FA Beidh, ... Intensive care medicine 47, 867-886, 2021 | 87 | 2021 |
| A qualitative research framework for the design of user-centered displays of explanations for machine learning model predictions in healthcare AJ Barda, CM Horvat, H Hochheiser BMC medical informatics and decision making 20, 1-16, 2020 | 83 | 2020 |
| Long-term (180-day) outcomes in critically ill patients with COVID-19 in the REMAP-CAP randomized clinical trial S Florescu, D Stanciu, M Zaharia, A Kosa, D Codreanu, A Kidwai, ... Jama 329 (1), 39-51, 2023 | 82 | 2023 |
| Blood biomarkers for detection of brain injury in COVID-19 patients ST DeKosky, PM Kochanek, AB Valadka, RSB Clark, SHY Chou, AK Au, ... Journal of neurotrauma 38 (1), 1-43, 2021 | 82 | 2021 |
| Effect of antiplatelet therapy on survival and organ support–free days in critically ill patients with COVID-19: a randomized clinical trial CA Bradbury, PR Lawler, SJ Stanworth, BJ McVerry, Z McQuilten, ... Jama 327 (13), 1247, 2022 | 79 | 2022 |
| Trends in bronchiolitis ICU admissions and ventilation practices: 2010–2019 JH Pelletier, AK Au, D Fuhrman, RSB Clark, C Horvat Pediatrics 147 (6), 2021 | 69 | 2021 |
| Phase I randomized clinical trial of N-acetylcysteine in combination with an adjuvant probenecid for treatment of severe traumatic brain injury in children RSB Clark, PE Empey, H Bayır, BL Rosario, SM Poloyac, PM Kochanek, ... PloS one 12 (7), e0180280, 2017 | 52 | 2017 |
| Machine learning to predict serious bacterial infections in young febrile infants S Ramgopal, CM Horvat, N Yanamala, ER Alpern Pediatrics 146 (3), 2020 | 47 | 2020 |
| Prescribing prevalence of medications with potential genotype-guided dosing in pediatric patients LB Ramsey, HH Ong, JS Schildcrout, Y Shi, LA Tang, JK Hicks, ... JAMA network open 3 (12), e2029411-e2029411, 2020 | 39 | 2020 |
| A persistent pesticide residue and the unusual catalytic proficiency of a dehalogenating enzyme CM Horvat, RV Wolfenden Proceedings of the National Academy of Sciences 102 (45), 16199-16202, 2005 | 38 | 2005 |
| Artificial intelligence-based clinical decision support in pediatrics S Ramgopal, LN Sanchez-Pinto, CM Horvat, MS Carroll, Y Luo, TA Florin Pediatric research 93 (2), 334-341, 2023 | 37 | 2023 |
| Paths to successful translation of new therapies for severe traumatic brain injury in the golden age of traumatic brain injury research: a Pittsburgh vision PM Kochanek, TC Jackson, RM Jha, RSB Clark, DO Okonkwo, H Bayır, ... Journal of neurotrauma 37 (22), 2353-2371, 2020 | 37 | 2020 |
| C-reactive protein and ferritin are associated with organ dysfunction and mortality in hospitalized children CM Horvat, J Bell, S Kantawala, AK Au, RSB Clark, JA Carcillo Clinical pediatrics 58 (7), 752-760, 2019 | 36 | 2019 |
| Heterogeneous treatment effects of therapeutic-dose heparin in patients hospitalized for COVID-19 EC Goligher, PR Lawler, TP Jensen, V Talisa, LR Berry, E Lorenzi, ... Jama 329 (13), 1066-1077, 2023 | 34 | 2023 |
